Sabra Healthcare REIT, Inc. $SBRA Shares Sold by Invesco Ltd.

Key Points

• Invesco Ltd. has reduced its stake in Sabra Healthcare REIT by 1.1%, holding approximately $44.18 million worth of shares after selling 27,374 shares during the first quarter.
• A number of institutional investors have increased their positions in Sabra Healthcare, with UMB Bank raising its stake by 379.6% in the same period.
• Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, resulting in an annualized dividend yield of 6.5%.

Invesco Ltd. reduced its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 1.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,528,844 shares of the real estate investment trust's stock after selling 27,374 shares during the quarter. Invesco Ltd. owned 1.06% of Sabra Healthcare REIT worth $44,179,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC bought a new stake in shares of Sabra Healthcare REIT in the first quarter valued at about $298,000. New York State Teachers Retirement System raised its holdings in Sabra Healthcare REIT by 12.1% in the first quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust's stock worth $5,619,000 after purchasing an additional 34,591 shares in the last quarter. M&T Bank Corp raised its holdings in Sabra Healthcare REIT by 2.1% in the first quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust's stock worth $905,000 after purchasing an additional 1,059 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its holdings in Sabra Healthcare REIT by 4.7% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust's stock worth $331,000 after purchasing an additional 853 shares in the last quarter. Finally, Oppenheimer & Co. Inc. purchased a new stake in shares of Sabra Healthcare REIT during the first quarter worth about $578,000. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock traded up $0.1570 during mid-day trading on Thursday, hitting $19.6170. The company had a trading volume of 1,029,328 shares, compared to its average volume of 2,451,278. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company's fifty day moving average is $18.39 and its 200-day moving average is $17.65. The company has a market capitalization of $4.70 billion, a price-to-earnings ratio of 25.79, a P/E/G ratio of 1.57 and a beta of 0.86.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 EPS for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The business had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. During the same quarter in the prior year, the firm posted $0.36 EPS. The business's quarterly revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.1%. The ex-dividend date is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio is currently 157.89%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on SBRA shares. JMP Securities boosted their price target on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. Scotiabank boosted their price target on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, Sabra Healthcare REIT currently has a consensus rating of "Moderate Buy" and a consensus price target of $20.00.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.